Xcout IntelGlaukos Corporation
Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Subscribe to see Glaukos Corporation’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Glaukos Corporation at a glance
Glaukos Corporation is a medical devices company headquartered in Aliso Viejo, United States. It is publicly listed (GKOS) with a market capitalisation of $9.8B. Xcout tracks 18 named people at Glaukos Corporation, including Thomas William Burns (Chairman & Chief Executive Officer).
Glaukos Corporation leadership
- Thomas William BurnsChairman & Chief Executive Officer
- Joseph E. GilliamPresident & Chief Operating Officer
- Alex R. ThurmanSenior Vice President & Chief Financial Officer
- Tomas NavratilChief Development Officer
- L. Jay Katz FACSChief Medical Officer
- Michele AllegrettoSenior Vice President of Human Resources
12 more named people on record for Glaukos Corporation, with roles, board committees and tenure — see the full roster →
Glaukos Corporation competitors
A few of Glaukos Corporation's closest competitors — see the full list of competitors and alternatives →
Avedro, Inc. is a company that developed novel therapies for the treatment of corneal disorders, glaucoma, and retinal diseases before being acquired by Glaukos Corporation.
Eximore is a biopharmaceutical platform company headquartered in Israel that is focused on designing innovative solutions for the ophthalmological community. The company develops revolutionary integrated therapeutic delivery systems to address complex eye care needs.
Eye Bright Medical Technology Co., Ltd., established in 2010 in Beijing, China, specializes in crafting a diverse array of ophthalmic medical solutions. The company's extensive product line is geared towards addressing various ocular conditions and visual impairments, encompassing surgical implants, specialized instruments, and diagnostic equipment, as well as optometric lenses and pharmaceutical eye drops. These innovations are developed to provide treatment for a range of eye diseases, notably cataracts, glaucoma, and refractive errors, among other ophthalmic issues.
Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers. Its leading investigational product is the HEPZATO KIT, a unique hepatic delivery system for melphalan that targets high-dose chemotherapy specifically to the liver. This innovative approach aims to substantially reduce systemic drug exposure and mitigate associated side effects. HEPZATO's clinical evaluation is advancing through the FOCUS trial, which is designed to assess the objective response rate in individuals with metastatic uveal melanoma whose disease is primarily concentrated in the liver. Furthermore, the company offers a separate version of HEPZATO as a medical device in Europe, marketed under the CHEMOSAT Hepatic Delivery System brand (or simply CHEMOSAT). This system empowers European medical centers to manage a diverse array of liver cancer conditions. Delcath Systems, Inc. was established in 1988, with its corporate headquarters situated in New York, New York.
Sirtex Medical is a global healthcare company founded in 1997 with its U.S. headquarters in Woburn, Massachusetts. The company specializes in improving patient outcomes, offering products such as SIR-Spheres yttrium-90 microspheres, and maintains offices across the U.S., Australia, Germany, and Singapore.
New World Medical, Inc. is a pioneering medical technology company founded in 1990 and headquartered in Rancho Cucamonga, California. The firm designs and manufactures ophthalmic devices aimed at improving the treatment of glaucoma.
Get Glaukos Corporation's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Glaukos Corporation in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access